# Sphenopalatine Ganglion Block for Nasal Surery

> **NCT04168879** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 110 (actual)

## Conditions studied

- Emergence Agitation

## Interventions

- **DRUG:** Bupivacaine 0.5% Preservative-Free Injectable Solution
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT04168879
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-10
- **Primary completion:** 2023-12-10
- **Final completion:** 2023-12-10
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04168879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04168879, "Sphenopalatine Ganglion Block for Nasal Surery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04168879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*